IRIS
DI BIASE, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.813
NA - Nord America 16.373
AS - Asia 13.976
SA - Sud America 2.664
AF - Africa 193
Continente sconosciuto - Info sul continente non disponibili 92
OC - Oceania 16
Totale 50.127
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.104
CN - Cina 5.971
IE - Irlanda 5.281
UA - Ucraina 4.493
SG - Singapore 3.422
RU - Federazione Russa 2.570
BR - Brasile 2.230
SE - Svezia 1.694
HK - Hong Kong 1.474
VN - Vietnam 904
FI - Finlandia 842
TR - Turchia 839
IN - India 778
FR - Francia 617
DE - Germania 380
IT - Italia 318
GB - Regno Unito 282
AR - Argentina 176
CA - Canada 106
MX - Messico 106
BD - Bangladesh 100
EU - Europa 85
IQ - Iraq 77
EC - Ecuador 73
ID - Indonesia 68
AT - Austria 65
ZA - Sudafrica 61
PL - Polonia 56
CO - Colombia 54
RO - Romania 43
PK - Pakistan 42
JP - Giappone 40
MA - Marocco 36
UZ - Uzbekistan 34
SA - Arabia Saudita 32
NL - Olanda 31
VE - Venezuela 31
PY - Paraguay 30
CL - Cile 28
BE - Belgio 27
TN - Tunisia 26
ES - Italia 22
PH - Filippine 20
EG - Egitto 18
JO - Giordania 18
PE - Perù 17
AU - Australia 14
DZ - Algeria 14
UY - Uruguay 14
AE - Emirati Arabi Uniti 13
NP - Nepal 13
AZ - Azerbaigian 12
CZ - Repubblica Ceca 12
IL - Israele 12
DO - Repubblica Dominicana 11
IR - Iran 11
KE - Kenya 11
KZ - Kazakistan 11
OM - Oman 11
TH - Thailandia 10
GR - Grecia 9
JM - Giamaica 9
PT - Portogallo 9
BO - Bolivia 8
CR - Costa Rica 8
KR - Corea 8
MY - Malesia 8
PS - Palestinian Territory 8
BG - Bulgaria 7
HN - Honduras 7
LB - Libano 7
AL - Albania 6
ET - Etiopia 6
LT - Lituania 6
PA - Panama 6
BH - Bahrain 5
CH - Svizzera 5
CI - Costa d'Avorio 5
HR - Croazia 5
HU - Ungheria 5
KW - Kuwait 5
DK - Danimarca 4
GA - Gabon 4
LV - Lettonia 4
RS - Serbia 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
GT - Guatemala 3
GY - Guiana 3
KH - Cambogia 3
LU - Lussemburgo 3
MD - Moldavia 3
NG - Nigeria 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CU - Cuba 2
GE - Georgia 2
Totale 50.090
Salva come PNG Salva come JPEG
Città #
Dublin 5.273
Jacksonville 3.168
San Jose 2.502
Nanjing 1.693
Hong Kong 1.467
Singapore 1.387
Chandler 973
Ashburn 909
Dearborn 908
Nyköping 888
Wilmington 854
Beijing 758
Santa Clara 682
Nanchang 662
Princeton 636
San Mateo 554
Lauterbourg 545
Moscow 478
Dallas 394
Shenyang 334
Ho Chi Minh City 323
Hebei 287
Tianjin 269
Kunming 245
Helsinki 206
Jiaxing 204
São Paulo 191
Hanoi 165
Changsha 151
Ann Arbor 150
Hangzhou 149
New York 149
Boardman 146
Des Moines 117
Jinan 107
Guangzhou 99
Hilden 92
Los Angeles 81
Changchun 75
Zhengzhou 75
Shanghai 72
Ningbo 71
Woodbridge 68
Dong Ket 67
Lanzhou 67
Stevenage 67
Nuremberg 66
The Dalles 62
Rio de Janeiro 61
Belo Horizonte 51
Warsaw 43
Mexico City 42
Norwalk 41
Porto Alegre 40
Curitiba 39
Taizhou 39
Timisoara 39
Frankfurt am Main 38
Haiphong 38
Orange 33
Tashkent 31
Brasília 30
Tokyo 29
Vienna 29
Baghdad 28
Biên Hòa 28
Campinas 28
Fuzhou 28
Chicago 27
Da Nang 27
Milan 27
San Francisco 27
Toronto 27
Redwood City 26
Brooklyn 25
Council Bluffs 25
Quito 25
Guayaquil 24
Wuhan 24
Montreal 23
Orem 22
Dhaka 21
Johannesburg 21
Manaus 21
Salvador 21
Thái Bình 20
Cape Town 19
London 19
Boston 18
Chennai 18
Guarulhos 18
Jinhua 18
Rome 18
Volta Redonda 18
Hanover 17
Hefei 17
Manchester 17
Recife 17
Amman 16
Asunción 16
Totale 30.300
Salva come PNG Salva come JPEG
Nome #
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing 165
3-D Assessment of Myocardial Ablation Lesions using Ultrasound-guided Spectroscopic Photoacoustic Imaging 150
A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality 146
Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies 136
QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study 135
2D and 3D TEE evaluation of an early Reopening of the LARIAT Epicardial left atrial appendage closure device. 126
[Takotsubo cardiomyopathy: current evidence from observational studies and pathophysiological background] 124
Near zerO fluoroscopic exPosure during catheter ablAtion of supRavenTricular arrhYthmias: the NO-PARTY multicentre randomized trial 122
Ablation of atrial arrhythmias in heart failure 121
Statins do not reduce atrial fibrillation recurrence after pulmonary vein isolation in postmenopausal females 120
Is a dual-sensor pacemaker appropriate in patients with sino-atrial disease? Results from the DUSILOG Study 119
Feasibility of combined unipolar and bipolar voltage maps to improve sensitivity of endomyocardial biopsy 119
Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy the VISTA Randomized Multicenter Trial 119
Preferential Association of Biomarkers With Non-paroxysmal Atrial Fibrillation Indicates The Role of Inflammation in Persistence of the Arrhythmia 117
Esophageal Capsule Endoscopy After Radiofrequency Catheter Ablation for Atrial Fibrillation Documented Higher Risk of Luminal Esophageal Damage With General Anesthesia as Compared With Conscious Sedation 116
Mortality of Heart Failure Patients After Cardiac Resynchronization Therapy: Identification of Predictors 116
Amiodarone increases the AF termination during ablation but reduces the long term success rate of patients undergoing ablation of long-standing persistent atrial fibrillation: preliminary results from the speculate study 116
Ablation as First-Line Therapy for Atrial Fibrillation 116
Ablation for Atrial Fibrillation 115
A Practical ECG Criterion to Unmask Left Accessory AV Connections in Patients With Subtle Preexcitation 115
Dynamic changes of QTc interval and prognostic significance in takotsubo (stress) cardiomyopathy 114
Pulmonary vein antrum isolation, atrioventricular junction ablation, and antiarrhythmic drugs combined with direct current cardioversion: survival rates at 7 years follow-up 113
Aggressive Life-style Modifications Facilitate Arrhythmia-free Survival in Atrial Fibrillation Patients With Coexistent Metabolic Syndrome and Sleep Apnea Having Sporadic Recurrence Following First Ablation Procedure Sanghamitra Mohanty, Prasant Mohanty, Lui 113
Impact of gender on outcomes after atrial fibrillation ablation 112
Ablating the Posterior Heart: Cardioesophageal Fistula Complicating Radiofrequency Ablation in the Coronary Sinus 112
Outcomes of atrioesophageal fistula following catheter ablation of atrial fibrillation treated with surgical repair versus esophageal stenting 111
Catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia 110
Visual, tactile, and contact force feedback: which one is more important for catheter ablation? Results from an in vitro experimental study. 110
EFFECT OF CATHETER ABLATION ON THE CLINICAL COURSE OF MIGRAINE IN ATRIAL FIBRILLATION PATIENTS WITH OR WITHOUT PRE-EXISTENT MIGRAINE: RESULTS FROM A PROSPECTIVE STUDY (CONFIRM) 110
Pacing site and bradycardia dependent retrograde conduction block over an atrioventricular accessory pathway 109
Atrial fibrillation termination mode comparing three common ablation strategies for permanent atrial fibrillation: results from a randomized study. 109
DOES TERMINATION OF ATRIAL FIBRILLATION DURING ABLATION OF LONG STANDING PERSISTENT ATRIAL FIBRILLATION PREDICT THE OUTCOME AT FOLLOW-UP? RESULTS FROM A PROSPECTIVE RANDOMIZED STUDY 109
Outcomes of Atrio-Esophageal Fistula Following Catheter Ablation of Atrial Fibrillation Treated With Esophageal Stent: a Case Series 109
Endo-epicardial ablation of ventricular arrhythmias in the left ventricle with the Remote Magnetic Navigation System and the 3.5-mm open irrigated magnetic catheter: results from a large single-center case-control series 108
Ventricular Tachycardia Ablation—For Whom, When, and How? 108
[Catheter ablation of atrial fibrillation: an update from the most important trials]. 108
Prognostic value of automatically detected early repolarization 108
Reply: A Prima Vista Ablation of Ventricular Tachycardia: Should We Abandon the Mapping of VT? 108
Chronicling the evolution of catheter ablation for atrial fibrillation and ventricular tachycardia. 107
Dabigratan Has a Higher Risk of Left Atrial Appendage Thrombus Formation in Patients With Af When Compared to Warfarin and Rivaroxaban 107
Pulmonary Vein Isolation to Reduce Future Risk of Atrial Fibrillation in Patients Undergoing Typical Flutter Ablation: Results from a Randomized Pilot Study (REDUCE AF) 107
Validation of the Framingham Heart Study and CHARGE-AF Risk Scores for Atrial Fibrillation in Hispanics, African-Americans, and Non-Hispanic Whites 107
Cerebrovascular Complications Related to Atrial Fibrillation Ablation and Strategies for Periprocedural Stroke Prevention 106
Ablation for atrial fibrillation: termination of atrial fibrillation is not the endpoint. Contemporary debates and Controversies in Cardiac Electrophysiology, Part II 106
Robotic navigation for catheter ablation: benefits and challenges 106
Safety and feasibility of levosimendan administration in Takotsubo Cardiomyopathy: A case series 105
Women have a Two-fold Higher Risk for Developing Cardiac Tamponade during AF Ablation Procedures: Results from a Multicenter International Survey in 27,249 Cases. 105
Catheter Ablation for Long-Standing Persistent Atrial Fibrillation 104
Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium 104
Biomarkers of myocardial injury with different energy sources for atrial fibrillation catheter ablation. 103
Remote magnetic navigation for atrial fibrillation ablation: is ‘As Good as Manual’ good enough 103
Pulmonary vein calcification by EBCT in patients with drug refractory nonvalular atrial fibrillation 103
Mechanical and electrical alternans in heart failure patients implanted with biventricular pacemakers. 103
Metodo di mappaggio ed ablazione transcatetere di aritmie ventricolari attraverso il seno di Valsalva descrizione di due casi. 103
Hybrid strategies for Ablation of permanent AF as an Adjunct to PVI: implications of targeting AF NEST in sinus Rhythm and CFAE in AF. 103
Management of refractory atrial fibrillation post surgical ablation. 103
Intracardiac Echo Findings Post Atrial Fibrillation Ablation Are an Important Predictor of Late Pericardial Effusion 103
Silent Cerebral Events/Lesions Related to Atrial Fibrillation Ablation: A Clinical Review 103
Impact of Systematic Isolation of Superior Vena Cava in Addition to Pulmonary Vein Antrum Isolation on the Outcome of Paroxysmal, Persistent, and Permanent Atrial Fibrillation Ablation: Results from a Randomized Study 102
Atrial fibrillation ablation using a robotic catheter remote control system: initial human experience and long-term follow-up results 102
Reverse remodelling induced by resynchronization therapy is associated to renin-angiotensin system activity improvement 102
A novel technique to achieve better lesions in the coronary sinus: safety and feasibility. 102
Ablation of an accessory pathway: endocardial and epicardial mapping 101
[Catheter ablation as first-line therapy for atrial fibrillation: an analysis of available evidence]. 101
How to Ablate Long-Standing, Persistent Atrial Fibrillation Using a Step-Wise Approach (The Natale Approach) 101
Zero Fluoroscopy Ablation of Atrial Fibrillation: A Safety and Feasibility Study 101
Real Time Monitoring of Tip Electrode-Tissue Orientation and Contact Force: Optimizing Accuracy and Safety of Mapping and Ablation Procedures. 100
Current and previous smoking increases mortality in patients on cardiac resynchronization therapy 100
Acute and early outcomes of focal impulse and rotor modulation (FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation 100
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial 100
Ablation of atrial fibrillation under therapeutic INR reduces periprocedural complications: time to change the guidelines? 99
Prevalence and Management of Atrial Fibrillation in Middle-Aged/Older Athletes 99
Systematic fluoroscopic and electrical assessment of implantable cardioverter-defibrillator patients implanted with silicone-polyurethane copolymer (Optim™) coated leads. 99
Effect of periprocedural amiodarone on procedure outcome in longstanding persistent atrial fibrillation undergoing extended pulmonary vein antrum isolation: Results from a randomized study (SPECULATE) 99
Age-dependent impact of fluoroscopic radiation on the gender of off-spring: An international survey of cardiologists 99
Influence of Hospital Characteristics and Operator Volume on Adverse Outcomes of Atrial Fibrillation Ablation 99
Association of pretreatment with angiotensin-converting enzyme inhibitors with improvement in ablation outcome in atrial fibrillation patients with low left ventricular ejection fraction 99
Novel association of polymorphic genetic variants with predictors of outcome of catheter ablation in atrial fibrillation: new directions from a prospective study (DECAF) 99
Long-term safety and efficacy of supraventricular tachycardia ablation with a simplified approach 99
Pulmonary Vein Total Occlusion Following Catheter Ablation for Atrial Fibrillation: Clinical implications after long term follow up 98
OPEN IRRIGATION CATHETERS GENERATE HIGHER ESOPHAGEAL TISSUE TEMPERATURES THAN STANDARD 8MM TIP CATHETERS WHEN ABLATING WITHIN THE LEFT ATRIUM. 98
Catheter ablation of ventricular arhhythmias with the remote magnetic navigation system and the 3.5 mm openirrigated magnetic catheter: results from a large single center series 98
Impact of cardiac resynchronization therapy on the severity of mitral regurgitation 98
Left Atrial Appendage Occlusion Device and Novel Oral Anticoagulants versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Control Trials 98
Impact of uncontrolled hypertension on atrial fibrillation ablation outcome 98
Is ablation of atrial fibrillation in patients with chronic left atrial appendage thrombus safe? 97
Assenza di eventi cardiaci maggiori in pazienti che presentano rimodellamento inverso e riduzione dei markers infiammatorii al follow-up dopo impianto di pacemaker biventricolare per scompenso cardiaco. 97
La crioablazione nel trattamento delle aritmie correlate a via accessoria antero e medio-settale: risultati acuti ed a lungo termine. 97
Safety and efficacy in females undergoing pulmonary vein isolation. 97
Graded effect left ventricular ejection fraction on outcomes of ventricular tachycardia ablation: a multicenter experience 97
Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study. 97
Role of intracardiac echocardiography in atrial fibrillation ablation 97
Feasibility and Safety of Uninterrupted Rivaroxaban in Patients Undergoing Radiofrequency Ablation for Long Standing Persistent Atrial Fibrillation 97
Baseline Neutrophil/Lymphocyte Ratio Predicts Recurrences After Radiofrequency Catheter Ablation: Results From Prospective Study on Paroxysmal Atrial Fibrillation 97
Initial real world experience with a novel insertable (Reveal LinQ(@Medtronic)) compared to the conventional (Reveal XT(@Medtronic)) implantable loop recorder at a tertiary care center - Points to ponder! 97
Atrial Fibrillation Ablation and Stroke 97
AF termination as a procedural endpoint during ablation in long standing persistent atrial fibrillation 96
Haptoglobin Level at 24-Hour Post-Ablation Period Predicts Long-Term Recurrence-Free Survival in Atrial Fibrillation-Results From a Prospective Study (IMPACT) 96
Role of yoga as an adjunctive therapy in patients with neurocardiogenic syncope: a pilot study 96
Hybrid Procedure (Endo/Epicardial) versus Standard Manual Ablation in Patients Undergoing Ablation of Longstanding Persistent Atrial Fibrillation: Results from a Single Center 96
Totale 10.727
Salva come PNG Salva come JPEG
Categoria #
all - tutte 270.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 270.359
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021776 0 0 0 0 0 0 0 0 0 685 17 74
2021/20222.825 547 4 6 3 271 74 84 274 357 333 149 723
2022/20238.903 981 144 295 327 308 559 12 382 5.654 57 81 103
2023/2024815 149 49 48 34 74 216 30 36 15 11 9 144
2024/20257.419 301 40 94 105 83 1.071 628 396 2.824 641 489 747
2025/202611.608 639 729 1.554 2.624 273 420 2.614 1.310 908 537 0 0
Totale 51.070